| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |